Mannatech (MTEX) Competitors $7.82 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends MTEX vs. NAII, VHAQ, SYRS, KZR, BRNS, ATNM, SCYX, OCX, LVTX, and AFMDShould you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include Natural Alternatives International (NAII), Viveon Health Acquisition (VHAQ), Syros Pharmaceuticals (SYRS), Kezar Life Sciences (KZR), Barinthus Biotherapeutics (BRNS), Actinium Pharmaceuticals (ATNM), SCYNEXIS (SCYX), OncoCyte (OCX), LAVA Therapeutics (LVTX), and Affimed (AFMD). These companies are all part of the "pharmaceutical products" industry. Mannatech vs. Natural Alternatives International Viveon Health Acquisition Syros Pharmaceuticals Kezar Life Sciences Barinthus Biotherapeutics Actinium Pharmaceuticals SCYNEXIS OncoCyte LAVA Therapeutics Affimed Mannatech (NASDAQ:MTEX) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation. Does the MarketBeat Community prefer MTEX or NAII? Mannatech received 52 more outperform votes than Natural Alternatives International when rated by MarketBeat users. Likewise, 76.19% of users gave Mannatech an outperform vote while only 75.22% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformMannatechOutperform Votes30476.19% Underperform Votes9523.81% Natural Alternatives InternationalOutperform Votes25275.22% Underperform Votes8324.78% Which has more risk & volatility, MTEX or NAII? Mannatech has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Does the media favor MTEX or NAII? In the previous week, Mannatech had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for Natural Alternatives International. Mannatech's average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Natural Alternatives International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend MTEX or NAII? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANatural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has better valuation and earnings, MTEX or NAII? Mannatech has higher revenue and earnings than Natural Alternatives International. Mannatech is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMannatech$122.38M0.12-$2.24M-$0.63-12.41Natural Alternatives International$113.80M0.25-$7.22M-$1.23-3.70 Do institutionals & insiders have more ownership in MTEX or NAII? 13.0% of Mannatech shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 41.5% of Mannatech shares are owned by insiders. Comparatively, 20.9% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is MTEX or NAII more profitable? Mannatech has a net margin of -0.97% compared to Natural Alternatives International's net margin of -6.34%. Natural Alternatives International's return on equity of -8.47% beat Mannatech's return on equity.Company Net Margins Return on Equity Return on Assets Mannatech-0.97% -11.87% -2.88% Natural Alternatives International -6.34%-8.47%-4.57% SummaryMannatech beats Natural Alternatives International on 10 of the 14 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Mannatech News Delivered to You Automatically Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MTEX vs. The Competition Export to ExcelMetricMannatechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.74M$1.32B$5.40B$8.53BDividend YieldN/AN/A5.13%4.14%P/E Ratio-12.417.65115.5615.18Price / Sales0.128.081,484.3492.77Price / CashN/A15.7539.6634.07Price / Book1.392.094.665.02Net Income-$2.24M-$52.95M$119.06M$225.46M7 Day Performance3.99%-0.37%0.80%0.37%1 Month Performance2.76%6.66%5.65%3.57%1 Year Performance-6.12%11.97%36.76%29.44% Mannatech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MTEXMannatech0.8825 of 5 stars$7.82flatN/A-9.5%$14.74M$122.38M-12.41250Upcoming EarningsAnalyst ForecastNews CoverageNAIINatural Alternatives International0.9931 of 5 stars$4.53-5.6%N/A-24.4%$28.09M$113.80M-3.68290Analyst ForecastVHAQViveon Health AcquisitionN/A$10.00flatN/AN/A$56.60MN/A0.002SYRSSyros Pharmaceuticals4.6718 of 5 stars$2.11+5.5%$5.00+137.0%-5.2%$56.40M$4.15M-0.49120Earnings ReportAnalyst ForecastNews CoverageGap DownKZRKezar Life Sciences4.0456 of 5 stars$0.77-1.3%$4.50+482.5%-5.2%$56.36M$7M-0.5760Stock SplitBRNSBarinthus Biotherapeutics3.487 of 5 stars$1.41-5.4%$5.83+313.7%N/A$55.58M$800,000.00-0.85107Short Interest ↓News CoverageATNMActinium Pharmaceuticals1.4333 of 5 stars$1.83+9.0%$11.40+524.7%N/A$54.35M$81,000.00-1.2149Gap UpSCYXSCYNEXIS1.1769 of 5 stars$1.42-3.4%N/A-25.0%$53.76M$140.14M-1.9760Negative NewsOCXOncoCyte2.1563 of 5 stars$3.10+2.0%$4.06+31.0%+29.3%$52.17M$1.50M0.00120Analyst ForecastLVTXLAVA Therapeutics2.3512 of 5 stars$2.04+2.0%$6.00+194.8%+61.0%$51.59M$7.40M-2.2460Positive NewsGap DownAFMDAffimed3.7626 of 5 stars$3.37+1.2%$20.00+493.5%-8.3%$51.32M$2.68M0.0076News Coverage Related Companies and Tools Related Companies NAII Alternatives VHAQ Alternatives SYRS Alternatives KZR Alternatives BRNS Alternatives ATNM Alternatives SCYX Alternatives OCX Alternatives LVTX Alternatives AFMD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MTEX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mannatech, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Mannatech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
